Strong demand for gastrointestinal therapies has propelled steady growth in the Esomeprazole Market. Increasing cases of digestive disorders, higher healthcare investments, and enhanced access to medications have contributed significantly to market expansion. Esomeprazole, a leading proton pump inhibitor used to manage GERD, peptic ulcers, and Zollinger-Ellison syndrome, remains a cornerstone...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt